CLASS II ONGOING Device recall · Reported 15 Jul 2026 · FDA Enforcement Report

MiniMed Insulin Pump recalled by Medtronic MiniMed

Medtronic MiniMed is recalling MiniMed Insulin Pump. The recall was initiated on 27 May 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI/GTIN: A7630006392701, 00763000521554, 00763000639273, A7630006392301, 00199150035687, A7630007325603, A7630007325601, 00763000639235, A7630007325604, 00763000384289, 00763000521530, A7630007325401, 00763000521547, A7630006392601, A7630006392201, 00763000639228, 00199150035663, 00763000639266, A7630007325404, 00199150035694, 00763000442194, A7630007325403, 00763000521523. Software version 6.62
Quantity recalled778

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2698-2026
FDA event ID
99207
Recalling firm
Medtronic MiniMed, Northridge, CA
Classification
Class II
Status
Ongoing
Recall initiated
27 May 2026
FDA classified
8 Jul 2026
Reported
15 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Device Malfunction

Timeline

27 May 2026Recall initiated by company
8 Jul 2026Classified by FDA+42 days
15 Jul 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 followed immediately by Pump Error 23. Insulin delivery will stop which may lead to delayed therapy and an increased risk of hyperglycemia or diabetic ketoacidosis (DKA).

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

MiniMed 780G Insulin Pump, REF: MMT-1885, MMT-1886, MMT-1895, MMT-1896

Where it was distributed

International distribution to the countries of Spain, Great Britain, Netherlands, Italy.

Questions about this recall

Why was it recalled?

A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 followed immediately by Pump Error 23. Insulin delivery will stop which may lead to delayed therapy and an increased risk of hyperglycemia or diabetic ketoacidosis (DKA).

Which lots are affected?

UDI-DI/GTIN: A7630006392701, 00763000521554, 00763000639273, A7630006392301, 00199150035687, A7630007325603, A7630007325601, 00763000639235, A7630007325604, 00763000384289, 00763000521530, A7630007325401, 00763000521547, A7630006392601, A7630006392201, 00763000639228, 00199150035663, 00763000639266, A7630007325404, 00199150035694, 00763000442194, A7630007325403, 00763000521523. Software version 6.62

Where was it sold?

International distribution to the countries of Spain, Great Britain, Netherlands, Italy.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medtronic MiniMed

All 78

Other Insulin Pumps & Glucose Monitors recalls

All 466